Dimension Therapeutics Financial Statements Trends

DMTX -- USA Stock  

USD 5.95  0.00  0.00%

This module enables investors to look at Dimension Therapeutics various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Gross Profit of 11.5 M, Interest Expense of 107.1 K or Operating Expenses of 50.3 M, but also many exotic indicators such as Asset Turnover of 0.1176, Book Value per Share of 15.6247 or Current Ratio of 3.33. This module is a perfect complement to use when analyzing Dimension Therapeutics Valuation or Volatility. It can also complement various Dimension Therapeutics Technical models. Additionally see analysis of Dimension Therapeutics Correlation with competitors.

Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets133.3 M133.3 M59.2 M
Increasing
Slightly volatile
Cash and Equivalents47.5 M127 M47.7 M
Increasing
Slightly volatile
Deferred Revenue24.1 M20.5 M22.2 M
Decreasing
Stable
Trade and Non Trade Receivables168.2 K143 K1.4 M
Decreasing
Slightly volatile
Trade and Non Trade Payables2.4 M2.1 M1.7 M
Increasing
Slightly volatile
Total Liabilities32.6 M27.7 M27.4 M
Increasing
Slightly volatile
Shareholders Equity124.2 M105.6 M27.3 M
Increasing
Slightly volatile
Accumulated Retained Earnings Deficit(60.2 M)(51.2 M)(28.6 M)
Decreasing
Slightly volatile
Current Assets129.9 M129.9 M56.8 M
Increasing
Slightly volatile
Assets Non Current3.9 M3.3 M2.4 M
Increasing
Slightly volatile
Current Liabilities13.2 M13.2 M9.7 M
Increasing
Slightly volatile
Liabilities Non Current17 M14.5 M17.5 M
Decreasing
Slightly volatile
Total Debt5.8 M1.3 M1.8 M
Increasing
Slightly volatile
Debt Current675.3 K574 K438.4 K
Increasing
Slightly volatile
Debt Non Current892.9 K759 K1 M
Decreasing
Slightly volatile
Shareholders Equity USD124.2 M105.6 M27.3 M
Increasing
Slightly volatile
Cash and Equivalents USD149.5 M127 M56.2 M
Increasing
Slightly volatile
Total Debt USD1.6 M1.3 M1.5 M
Decreasing
Slightly volatile

Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues14.9 M7.8 M5 M
Increasing
Slightly volatile
Research and Development Expense40 M34 M20.5 M
Increasing
Slightly volatile
Operating Expenses50.3 M42.7 M25.3 M
Increasing
Slightly volatile
Interest Expense107.1 K91 K43 K
Increasing
Slightly volatile
Consolidated Income(41.2 M)(35.1 M)(20.8 M)
Decreasing
Slightly volatile
Net Income(53.2 M)(35.1 M)(21.8 M)
Decreasing
Slightly volatile
Preferred Dividends Income Statement Impact27.1 K23 K55.3 K
Decreasing
Slightly volatile
Net Income Common Stock(41.3 M)(35.1 M)(20.9 M)
Decreasing
Slightly volatile
Weighted Average Shares25.2 M7.9 M6.5 M
Increasing
Slightly volatile
Weighted Average Shares Diluted9.4 M7.9 M5.2 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT(41.1 M)(35 M)(20.8 M)
Decreasing
Slightly volatile
Revenues USD9.1 M7.8 M4.5 M
Increasing
Slightly volatile
Net Income Common Stock USD(41.3 M)(35.1 M)(20.9 M)
Decreasing
Slightly volatile
Earning Before Interest and Taxes USD(41.1 M)(35 M)(20.8 M)
Decreasing
Slightly volatile
Gross Profit11.5 M7.8 M4.7 M
Increasing
Slightly volatile
Operating Income(41.1 M)(35 M)(20.8 M)
Decreasing
Slightly volatile

Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(3 M)(2.5 M)(2 M)
Decreasing
Slightly volatile
Net Cash Flow from Financing169 M143.6 M54.3 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities (235.3 K)(200 K)947.7 K
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares76 M64.6 M65.6 M
Increasing
Slightly volatile
Net Cash Flow from Investing(2.9 M)(2.5 M)(2 M)
Decreasing
Slightly volatile
Net Cash Flow from Operations(55.8 M)(32 M)(6.8 M)
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents128.4 M109.1 M46.9 M
Increasing
Slightly volatile
Share Based Compensation1.6 M1.3 M521.3 K
Increasing
Slightly volatile

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(5.1882)(4.41)(3.9415)
Decreasing
Slightly volatile
Earnings per Diluted Share(2.13)(4.41)(3.6867)
Decreasing
Very volatile
Earnings per Basic Share USD(5.1882)(4.41)(3.9415)
Decreasing
Slightly volatile
Return on Average Equity(0.8764)(0.768)(0.777)
Decreasing
Slightly volatile
Return on Average Assets(0.3642)(0.451)(0.4438)
Increasing
Slightly volatile
Return on Invested Capital10.42248.8598.9893
Increasing
Slightly volatile
Gross Margin1.17651.01.0147
Increasing
Slightly volatile
Profit Margin(5.3247)(4.526)(4.7359)
Decreasing
Very volatile
EBITDA Margin(5.1988)(4.419)(4.638)
Decreasing
Very volatile
Return on Sales(5.3082)(4.512)(4.7097)
Decreasing
Stable
Asset Turnover0.11760.10.1015
Increasing
Slightly volatile
Enterprise Value over EBITDA(7.3576)(6.254)(6.346)
Decreasing
Slightly volatile
Enterprise Value over EBIT(7.0588)(6.0)(6.0882)
Decreasing
Slightly volatile
Price to Earnings Ratio(2.81)(2.558)(2.579)
Decreasing
Slightly volatile
Sales per Share1.14710.9750.8473
Increasing
Slightly volatile
Price to Sales Ratio10.0811.57111.4468
Decreasing
Slightly volatile
Price to Book Value4.132.6712.7926
Increasing
Slightly volatile
Debt to Equity Ratio16.00.2620.1462
Increasing
Slightly volatile
Current Ratio3.339.8424.4307
Increasing
Slightly volatile
Free Cash Flow per Share1.9(4.349)0.3804
Decreasing
Slightly volatile
Book Value per Share15.624713.2812.0623
Increasing
Slightly volatile
Tangible Assets Book Value per Share19.722416.7649.8272
Increasing
Slightly volatile

Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(41.2 M)(35.1 M)(20.8 M)
Decreasing
Slightly volatile
Market Capitalization150 M282 M271 M
Decreasing
Slightly volatile
Enterprise Value108.6 M214.2 M205.4 M
Decreasing
Slightly volatile
Invested Capital(4.9 M)(3.6 M)(2.1 M)
Decreasing
Slightly volatile
Average Equity53.8 M45.7 M46.4 M
Increasing
Slightly volatile
Average Assets91.4 M77.7 M78.8 M
Increasing
Slightly volatile
Invested Capital Average(4.6 M)(3.9 M)(4 M)
Decreasing
Slightly volatile
Tangible Asset Value156.8 M133.3 M61.1 M
Increasing
Slightly volatile
Free Cash Flow(40.7 M)(34.6 M)(7.3 M)
Decreasing
Slightly volatile
Working Capital116.7 M116.7 M47.1 M
Increasing
Slightly volatile

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Dimension Therapeutics Upcoming Company Events

Upcoming Quarterly ReportMarch 23, 2017
Next Earnings ReportMay 11, 2017
Additionally see analysis of Dimension Therapeutics Correlation with competitors. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.